Stay updated with breaking news from Niazi licensing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Last week the Federal Circuit handed down a pair of non-precedential decisions affirming the Patent Trial and Appeal Board (PTAB) in inter partes review (IPR) proceedings. This post. ....
After seven years of successful litigation, it was understandable that St. Jude Medical wanted to put its dispute with Niazi Licensing Corp. (NLC) to bed.. ....
This case is primarily about the Daubert standard as applied to expert testimony on damages. The Federal Circuit reversed the Northern District of California’s admission of expert. ....
Holding In Newron Pharms. v. Aurobindo, No. 21-cv-843 , the District Court of Delaware addressed several disputed terms in a patent related to the treatment of idiopathic Parkinson s disease. Based. | June 14, 2023 ....
In Niazi Licensing Corp. v. St. Jude Med. S.C., Inc., No. 21-1864 (Fed. Cir. Apr. 11, 2022), the Court of Appeals for the Federal Circuit ("Federal Circuit") reversed the district court's holding that the claim terms. ....